Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study
dc.contributor.author | İlhan, O. | |
dc.contributor.author | Özcan, Mühit | |
dc.contributor.author | Yalçın, Arzu | |
dc.contributor.author | Koç, H. | |
dc.contributor.author | Beksaç, Mehmet | |
dc.contributor.author | Ünal, Ali | |
dc.contributor.author | Gülbaş, Zafer | |
dc.contributor.author | Gürman, Günhan | |
dc.contributor.author | Dündar, Semra | |
dc.contributor.author | Ündar, Levent | |
dc.contributor.author | Payzin, Bahriye | |
dc.contributor.author | Akan, H. | |
dc.contributor.buuauthor | Tunalı, Ahmet | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Hemotoloji Anabilim Dalı. | tr_TR |
dc.date.accessioned | 2022-03-15T07:20:53Z | |
dc.date.available | 2022-03-15T07:20:53Z | |
dc.date.issued | 1997-11-15 | |
dc.identifier.citation | İlhan, O. vd. (1997). "Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study". Blood, 90(10), Supplement 1, Part 2, 3999-3999. | en_US |
dc.identifier.endpage | 3999 | tr_TR |
dc.identifier.issn | 0006-4971 | |
dc.identifier.issue | 10, Supplement 1, Part 2, | en_US |
dc.identifier.startpage | 3999 | tr_TR |
dc.identifier.uri | https://ashpublications.org/blood/issue/90/10 | |
dc.identifier.uri | http://hdl.handle.net/11452/25023 | |
dc.identifier.volume | 90 | tr_TR |
dc.identifier.wos | A1997YG42501308 | |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Soc Hematology | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | Blood | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Hematology | en_US |
dc.subject.wos | Hematology | en_US |
dc.title | Hematological and cytogenetic efficiency of interferon alpha 2a plus low dose cytarabine in chronic myelogenous leukemia: An interim analysis of multicenter study | en_US |
dc.type | Meeting Abstract | |
dc.wos.quartile | Q1 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: